These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32868526)

  • 1. Clinicopathologic Significance of EGFR Mutation and HPV Infection in Sinonasal Squamous Cell Carcinoma.
    Hongo T; Yamamoto H; Jiromaru R; Nozaki Y; Yasumatsu R; Hashimoto K; Yoneda R; Sugii A; Taguchi K; Masuda M; Nakagawa T; Oda Y
    Am J Surg Pathol; 2021 Jan; 45(1):108-118. PubMed ID: 32868526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV-related Sinonasal Carcinoma: Clinicopathologic Features, Diagnostic Utility of p16 and Rb Immunohistochemistry, and EGFR Copy Number Alteration.
    Jiromaru R; Yamamoto H; Yasumatsu R; Hongo T; Nozaki Y; Hashimoto K; Taguchi K; Masuda M; Nakagawa T; Oda Y
    Am J Surg Pathol; 2020 Mar; 44(3):305-315. PubMed ID: 31743130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus (HPV) and somatic EGFR mutations are essential, mutually exclusive oncogenic mechanisms for inverted sinonasal papillomas and associated sinonasal squamous cell carcinomas.
    Udager AM; McHugh JB; Goudsmit CM; Weigelin HC; Lim MS; Elenitoba-Johnson KSJ; Betz BL; Carey TE; Brown NA
    Ann Oncol; 2018 Feb; 29(2):466-471. PubMed ID: 29145573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activating KRAS mutations are characteristic of oncocytic sinonasal papilloma and associated sinonasal squamous cell carcinoma.
    Udager AM; McHugh JB; Betz BL; Montone KT; Livolsi VA; Seethala RR; Yakirevich E; Iwenofu OH; Perez-Ordonez B; DuRoss KE; Weigelin HC; Lim MS; Elenitoba-Johnson KS; Brown NA
    J Pathol; 2016 Aug; 239(4):394-8. PubMed ID: 27234382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-L1 expression, tumor-infiltrating lymphocytes, mismatch repair deficiency, EGFR alteration and HPV infection in sinonasal squamous cell carcinoma.
    Hongo T; Yamamoto H; Jiromaru R; Yasumatsu R; Kuga R; Nozaki Y; Hashimoto K; Matsuo M; Wakasaki T; Tamae A; Taguchi K; Toh S; Masuda M; Nakagawa T; Oda Y
    Mod Pathol; 2021 Nov; 34(11):1966-1978. PubMed ID: 34218257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR mutation and HPV infection in sinonasal inverted papilloma and squamous cell carcinoma.
    Cabal VN; Menendez M; Vivanco B; Potes-Ares S; Riobello C; Suarez-Fernandez L; Garcia-Marin R; Blanco-Lorenzo V; Lopez F; Alvarez-Marcos C; Llorente JL; Hermsen MA
    Rhinology; 2020 Aug; 58(4):368-376. PubMed ID: 32199023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of HPV infection, EGFR exon 20 mutations and LINE1 hypomethylation as risk factors for malignant transformation of sinonasal-inverted papilloma to squamous cell carcinoma.
    Sahnane N; Ottini G; Turri-Zanoni M; Furlan D; Battaglia P; Karligkiotis A; Albeni C; Cerutti R; Mura E; Chiaravalli AM; Castelnuovo P; Sessa F; Facco C
    Int J Cancer; 2019 Mar; 144(6):1313-1320. PubMed ID: 30411788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Frequency Targetable EGFR Mutations in Sinonasal Squamous Cell Carcinomas Arising from Inverted Sinonasal Papilloma.
    Udager AM; Rolland DCM; McHugh JB; Betz BL; Murga-Zamalloa C; Carey TE; Marentette LJ; Hermsen MA; DuRoss KE; Lim MS; Elenitoba-Johnson KSJ; Brown NA
    Cancer Res; 2015 Jul; 75(13):2600-2606. PubMed ID: 25931286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sinonasal papillomas: A single centre experience on 137 cases with emphasis on malignant transformation and EGFR/KRAS status in "carcinoma ex papilloma".
    Maisch S; Mueller SK; Traxdorf M; Weyerer V; Stoehr R; Iro H; Hartmann A; Agaimy A
    Ann Diagn Pathol; 2020 Jun; 46():151504. PubMed ID: 32203683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptionally Active HPV and Targetable EGFR Mutations in Sinonasal Inverted Papilloma: An Association Between Low-risk HPV, Condylomatous Morphology, and Cancer Risk?
    Mehrad M; Stelow EB; Bishop JA; Wang X; Haynes W; Oliver D; Chernock RD; Lewis JS
    Am J Surg Pathol; 2020 Mar; 44(3):340-346. PubMed ID: 31743131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR and KRAS mutations in Chinese patients with sinonasal inverted papilloma and oncocytic papilloma.
    Wang H; Li H; Hu L; Zhou J; Zhai C; Wang D; Sun X
    Histopathology; 2019 Aug; 75(2):274-281. PubMed ID: 30916792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV- associated sinonasal squamous cell carcinoma with FGFR3::TACC3 fusion. A rare case report.
    Tamiolakis P; Shah A; Dawson R; Ramasamy S; Hutchins GGA
    Oral Oncol; 2024 Oct; 157():106983. PubMed ID: 39126751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sinonasal squamous cell carcinoma and EGFR mutations: a molecular footprint of a benign lesion.
    Sasaki E; Nishikawa D; Hanai N; Hasegawa Y; Yatabe Y
    Histopathology; 2018 Dec; 73(6):953-962. PubMed ID: 30117182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcome and pattern of recurrence of sinonasal squamous cell carcinoma with EGFR-mutation and human papillomavirus.
    Nishikawa D; Sasaki E; Suzuki H; Beppu S; Sawabe M; Terada H; Sone M; Hanai N
    J Craniomaxillofac Surg; 2021 Jun; 49(6):494-500. PubMed ID: 33676817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent KRAS and HRAS mutations in squamous cell papillomas of the head and neck.
    Sasaki E; Masago K; Fujita S; Hanai N; Yatabe Y
    J Pathol Clin Res; 2020 Apr; 6(2):154-159. PubMed ID: 31960612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of transcriptionally-active high-risk human papillomavirus in sinonasal squamous cell carcinoma: Case series and a meta-analysis.
    Svajdler M; Nemcova J; Dubinsky P; Metelkova A; Svajdler P; Straka Ľ; Sakar R; Daum O; Michal M; Skalova A; Mezencev R
    Neoplasma; 2020 Nov; 67(6):1456-1463. PubMed ID: 32853018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of p16 expression is a risk factor for recurrence in sinonasal inverted papilloma.
    Menendez M; Cabal VN; Vivanco B; Suarez-Fernandez L; Lopez F; Llorente JL; Hermsen MA; Alvarez-Marcos C
    Rhinology; 2022 Dec; 60(6):453-461. PubMed ID: 36173184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas.
    Brown NA; Plouffe KR; Yilmaz O; Weindorf SC; Betz BL; Carey TE; Seethala RR; McHugh JB; Tomlins SA; Udager AM
    Mod Pathol; 2021 Jun; 34(6):1133-1142. PubMed ID: 33203919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR and BRAF mutations in inverted sinonasal papilloma - a more complex landscape?
    Zonnur S; Erbersdobler A; Schneider B
    Virchows Arch; 2021 May; 478(5):915-924. PubMed ID: 33048186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.